Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record.

Determination of the TLR4 Genotype Using Allele-Specific PCR

Open access
Lorenz, Eva, Frees, Kathy L., Schwartz, David A.·2001·BioTechniques

Abstract

Despite significant advances in understanding the molecular basis of sepsis and its associated immunological response, sepsis remains a problem worldwide and is associated with a high mortality. Annually, septic shock, the most severe form of sepsis, causes the death of more than 100 000 people in the USA (3,4). Gram-negative bacteria are the most common pathogens associated with bacterial infections in diseases such as meningitis and represent more than 50% of septic shock-related bacteria. Endotoxin or lipopolysaccharide (LPS), the main component of the cell wall of Gram-negative bacteria, has been shown to elicit an inflammatory response that mimics all of the features described in septic shock (2). Recently, we have reported the association of two common polymorphisms in the human TLR4 gene with hyporesponsiveness to inhaled LPS (1). These mutations consist of single nucleotide polymorphisms (SNPs) in the coding region of the gene, both of which result in missense mutations. Analysis of additional patients revealed an association between TLR4 genotype and susceptibility to Gram-negative infections (unpublished data). The frequency of these mutations was between 6% and 10% in all tested Caucasian populations, making this mutation a common enough polymorphism to be of diagnostic value (1). Because of the potential usefulness of the TLR4 mutation in risk-stratifying patients vulnerable to endotoxin-induced disease, we developed a quick and reliable PCR-based genotyping assay. By altering the forward PCR primers, we were able to generate mutant TLR4-specific restriction sites that allow TLR4 genotyping using a simple restriction digest following the PCR amplification of genomic patient DNA. Study populations were made available through collaborations with several clinical facilities as indicated. For the graft-versus-host disease (GVHD) sample population, DNA samples were obtained from a previously described cohort of patients (n = 237) who received a hematopoietic stem cell transplantation (HSCT) from a human leukocyte antigen (HLA)-identical sibling (5). All patients received methotrexate and cyclosporine for GVHD prophylaxis and had either grade 0 or grades II-IV acute GVHD. Patients with grade I GVHD, patients with renal failure requiring dialysis, and patients without GVHD who died before day 80 after transplantation were excluded. DNA purification was done using a commercially available kit. For childhood asthma cases, we identified 120 cases with symptomatic asthma at study entry and 240 controls without persistent asthma at study entry. Subjects must have buccal cell DNA available to be eligible. Some of the genomic DNA used was derived from whole blood and purified using commercially available kits, such as Gentra Systems (Minneapolis, MN, USA). DNA purified using kits works very well in this assay. DNA purified as crude lysate using the NaOH lysis method will work as well, although, in general, a larger amount of sample is required to yield sufficient amounts of PCR product. PCR primers were designed to allow a distinction of wild-type and mutant TLR4 alleles based on the presence of restriction enzyme recognition sites. In both cases, the forward primer sequences were altered to generate a restriction site in the mutant allele. The following primers were used: for TLR4 Asp299Gly, forward 5′-GATTAGCATACTTAGACTACTACCTCCATG-3′ and reverse 5′-GATCAACTTCTGAAAAAGCATTCCCAC-3′, and for TLR4 Thr399Ile, forward 5′-GGTTGCTGTTCTCAAAGTGATTTTGGGAGAA-3′ and reverse 5′-ACCTGAAGACTGGAGAGTGAGTTAAATGCT3′. The underlined bases in both forward primers indicate the nucleotide altered to create a NcoI (TLR4 Asp299Gly) and HinfI (TLR4 Thr399Ile) restriction site, respectively. Reactions are set up using the AmpliTaq® PCR kit (Applied Biosystems, Foster City, CA, USA). Other PCR kits, such as the Advantage cDNA-PCR kit (Clontech Laboratories, Palo Alto, CA, USA) will work equally well. In a total reaction volume of 25 μL, 2.5 μL 10× PCR buffer, 20 pmol each primer (see above), 0.02 μg (0.2 μg for crude lysate) genomic DNA, 5 U Taq DNA polymerase, and 1 μL dNTP mixture (Clontech Laboratories) are combined. Reactions are run on a MJ Tetrad PTC225 Thermo Cycler (MJ Research, Waltham, MA, USA) using the following conditions: 95°C for 4 min, then 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 30 s). Four microliters of the resulting PCR products are used for an overnight digest with the appropriate restriction enzyme, and digests are run out on a 3% NuSieve® GTG agarose gel (BMA, Rockland, ME, USA) to determine the TLR4 alleles. For the purpose of validating this method, 10 patient samples with different genotypes were sequenced directly using an ABI 377 sequencer (Applied Biosystems). Genomic DNA was amplified using forward 5′-TCTAGAGGGCCTGTGCAATT-3′ and reverse Benchmarks

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2144/01311bm01

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 185

Metadata

Authors
Lorenz, E., Frees, K. L., & Schwartz, D. A.
Venue
BioTechniques
Published
2001-07
Volume
31
Issue
1
Pages
22-24
ISSN
  • 0736-6205 (ISSN-L)
  • 1940-9818
OpenAlex
W112824597
Cited by
185
References
0
FWCI
2.21
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determination of the TLR4 Genotype Using Allele-Specific PCR. https://app.cochat.ai/papers/10.2144/01311bm01
The paper
Lorenz, E., Frees, K. L., & Schwartz, D. A. (2001). Determination of the TLR4 Genotype Using Allele-Specific PCR. BioTechniques. https://doi.org/10.2144/01311bm01

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.